Pfizer (PFE) Leases (2019 - 2024)
Historic Leases for Pfizer (PFE) over the last 6 years, with Q4 2024 value amounting to $2.3 billion.
- Pfizer's Leases fell 2171.68% to $2.3 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $2.3 billion, marking a year-over-year decrease of 2171.68%. This contributed to the annual value of $2.3 billion for FY2024, which is 2171.68% down from last year.
- Latest data reveals that Pfizer reported Leases of $2.3 billion as of Q4 2024, which was down 2171.68% from $2.9 billion recorded in Q4 2023.
- Pfizer's 5-year Leases high stood at $3.0 billion for Q4 2022, and its period low was $1.4 billion during Q4 2020.
- Its 5-year average for Leases is $2.5 billion, with a median of $2.8 billion in 2021.
- Per our database at Business Quant, Pfizer's Leases surged by 10483.41% in 2021 and then plummeted by 2171.68% in 2024.
- Over the past 5 years, Pfizer's Leases (Quarter) stood at $1.4 billion in 2020, then soared by 104.83% to $2.8 billion in 2021, then increased by 5.74% to $3.0 billion in 2022, then decreased by 2.6% to $2.9 billion in 2023, then dropped by 21.72% to $2.3 billion in 2024.
- Its last three reported values are $2.3 billion in Q4 2024, $2.9 billion for Q4 2023, and $3.0 billion during Q4 2022.